Advanced Medical Solutions Group (AMS) Competitors

GBX 194.20
+4.80 (+2.53%)
(As of 05/1/2024 ET)

AMS vs. TSTL, BMK, MXCT, NIOX, PRTC, BVXP, UPR, OXB, HVO, and APH

Should you be buying Advanced Medical Solutions Group stock or one of its competitors? The main competitors of Advanced Medical Solutions Group include Tristel (TSTL), Benchmark (BMK), MaxCyte (MXCT), NIOX Group (NIOX), PureTech Health (PRTC), Bioventix (BVXP), Uniphar (UPR), Oxford Biomedica (OXB), hVIVO (HVO), and Alliance Pharma (APH). These companies are all part of the "medical" sector.

Advanced Medical Solutions Group vs.

Tristel (LON:TSTL) and Advanced Medical Solutions Group (LON:AMS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk, analyst recommendations and community ranking.

50.3% of Tristel shares are owned by institutional investors. Comparatively, 66.9% of Advanced Medical Solutions Group shares are owned by institutional investors. 5.4% of Tristel shares are owned by company insiders. Comparatively, 2.6% of Advanced Medical Solutions Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Advanced Medical Solutions Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£39.49M5.56£6.04M£0.133,557.69
Advanced Medical Solutions Group£126.21M3.34£15.89M£0.072,774.29

In the previous week, Advanced Medical Solutions Group had 1 more articles in the media than Tristel. MarketBeat recorded 1 mentions for Advanced Medical Solutions Group and 0 mentions for Tristel. Tristel's average media sentiment score of 1.86 beat Advanced Medical Solutions Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
Tristel Neutral
Advanced Medical Solutions Group Very Positive

Tristel has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Comparatively, Advanced Medical Solutions Group has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 2.8%. Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. Tristel pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 2,857.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Advanced Medical Solutions Group received 16 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.70% of users gave Advanced Medical Solutions Group an outperform vote.

CompanyUnderperformOutperform
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%
Advanced Medical Solutions GroupOutperform Votes
164
49.70%
Underperform Votes
166
50.30%

Tristel has a net margin of 15.29% compared to Tristel's net margin of 12.59%. Advanced Medical Solutions Group's return on equity of 20.35% beat Tristel's return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.29% 20.35% 9.89%
Advanced Medical Solutions Group 12.59%6.61%4.14%

Tristel presently has a consensus price target of GBX 390, indicating a potential downside of 15.68%. Advanced Medical Solutions Group has a consensus price target of GBX 300, indicating a potential upside of 54.48%. Given Tristel's higher possible upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tristel
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Advanced Medical Solutions Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Tristel and Advanced Medical Solutions Group tied by winning 9 of the 18 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMS vs. The Competition

MetricAdvanced Medical Solutions GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£422.07M£2.98B£4.87B£1.45B
Dividend Yield1.32%1.89%2.85%11.77%
P/E Ratio2,774.29321.20248.251,801.44
Price / Sales3.34172.432,400.16362,431.92
Price / Cash7.87105.0146.7431.70
Price / Book1.702.804.742.53
Net Income£15.89M£76.43M£102.65M£182.66M
7 Day Performance1.04%-2.68%1.95%0.60%
1 Month Performance-0.92%-6.95%-5.42%8.69%
1 Year Performance-20.73%-7.21%4.96%17.61%

Advanced Medical Solutions Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSTL
Tristel
0.131 of 5 stars
GBX 455
+2.2%
GBX 390
-14.3%
+42.0%£216.08M£39.49M3,500.00208
BMK
Benchmark
0 of 5 stars
GBX 46
+4.3%
N/A+8.0%£340.19M£155.53M-1,533.33823Gap Down
MXCT
MaxCyte
0 of 5 stars
GBX 323
+2.5%
N/A-24.4%£336.34M£41.29M-1,113.79143
NIOX
NIOX Group
0.189 of 5 stars
GBX 66.80
+1.5%
GBX 77
+15.3%
+53.7%£282.40M£36.80M3,340.0092High Trading Volume
PRTC
PureTech Health
0 of 5 stars
GBX 213
+3.6%
N/A+3.1%£574.99M£11.74M-1,638.46300Gap Up
BVXP
Bioventix
0 of 5 stars
GBX 4,475
-1.1%
N/A+12.4%£233.60M£13.60M2,745.4012News Coverage
Positive News
UPR
Uniphar
0 of 5 stars
GBX 220
flat
N/A-16.4%£600.64M£2.55B1,571.432,800
OXB
Oxford Biomedica
1.2236 of 5 stars
GBX 215
+1.2%
GBX 498.75
+132.0%
-37.9%£214.91M£119.02M-335.94891News Coverage
Negative News
High Trading Volume
HVO
hVIVO
0 of 5 stars
GBX 28.25
+2.7%
N/A+75.4%£192.21M£60.48M-1.00N/A
APH
Alliance Pharma
2.3414 of 5 stars
GBX 35.50
-1.8%
GBX 80.75
+127.5%
-46.6%£191.84M£170.05M-3,550.00285News Coverage

Related Companies and Tools

This page (LON:AMS) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners